Literature DB >> 12724730

Translational strategies for cancer prevention in liver.

Thomas W Kensler1, Geng-Sun Qian, Jian-Guo Chen, John D Groopman.   

Abstract

Unlike many other types of human cancer, the aetiology of liver cancer is well understood. Infection with hepatitis viruses, coupled with dietary exposure to the fungal toxin aflatoxin, increases the risk of the disease. Although primary prevention, based on vaccination and avoiding exposure to these agents, is an appealing option, such strategies will require considerable investment of time and resources to be successful. In the developing world--where the burden of liver cancer is highest--immediate, practical and economical approaches are essential. So, targeted chemoprevention might be most appropriate for the present generation of individuals at risk.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12724730     DOI: 10.1038/nrc1076

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  63 in total

1.  Sulforaphane-mediated reduction of aflatoxin B₁-N⁷-guanine in rat liver DNA: impacts of strain and sex.

Authors:  Jeannette L A Fiala; Patricia A Egner; Nirachara Wiriyachan; Mathuros Ruchirawat; Kevin H Kensler; Gerald N Wogan; John D Groopman; Robert G Croy; John M Essigmann
Journal:  Toxicol Sci       Date:  2011-01-28       Impact factor: 4.849

2.  Prevention of hepatocellular carcinoma.

Authors:  Michael C Kew
Journal:  HPB (Oxford)       Date:  2005       Impact factor: 3.647

Review 3.  DNA adducts with lipid peroxidation products.

Authors:  Ian A Blair
Journal:  J Biol Chem       Date:  2008-02-19       Impact factor: 5.157

4.  Translational research in environmental health sciences.

Authors:  Elizabeth M Denholm; William J Martin
Journal:  Transl Res       Date:  2007-10-09       Impact factor: 7.012

5.  Sustained JNK1 activation is associated with altered histone H3 methylations in human liver cancer.

Authors:  Qingshan Chang; Yadong Zhang; Kevin J Beezhold; Deepak Bhatia; Hongwen Zhao; Jianguo Chen; Vince Castranova; Xianglin Shi; Fei Chen
Journal:  J Hepatol       Date:  2008-10-16       Impact factor: 25.083

Review 6.  Molecular alterations in prostate cancer as diagnostic, prognostic, and therapeutic targets.

Authors:  Bora Gurel; Tsuyoshi Iwata; Cheryl M Koh; Srinivasan Yegnasubramanian; William G Nelson; Angelo M De Marzo
Journal:  Adv Anat Pathol       Date:  2008-11       Impact factor: 3.875

Review 7.  Nrf2:INrf2 (Keap1) signaling in oxidative stress.

Authors:  James W Kaspar; Suryakant K Niture; Anil K Jaiswal
Journal:  Free Radic Biol Med       Date:  2009-08-07       Impact factor: 7.376

8.  Changing rates for liver and lung cancers in Qidong, China.

Authors:  Jian-Guo Chen; Thomas W Kensler
Journal:  Chem Res Toxicol       Date:  2013-11-20       Impact factor: 3.739

Review 9.  Aflatoxins, hepatocellular carcinoma and public health.

Authors:  Arvin Magnussen; Mansour A Parsi
Journal:  World J Gastroenterol       Date:  2013-03-14       Impact factor: 5.742

10.  Hepatitis B virus infection contributes to oxidative stress in a population exposed to aflatoxin B1 and high-risk for hepatocellular carcinoma.

Authors:  Zhi-Ming Liu; Le-Qun Li; Min-Hao Peng; Tang-Wei Liu; Zhong Qin; Ya Guo; Kai-Yin Xiao; Xin-Ping Ye; Xin-Shao Mo; Xue Qin; Shan Li; Lu-Nan Yan; Han-Ming Shen; LianWen Wang; Qiao Wang; Kai-bo Wang; Ren-xiang Liang; Zong-liang Wei; Choon Nam Ong; Regina M Santella; Tao Peng
Journal:  Cancer Lett       Date:  2008-02-15       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.